K-V Pharmaceutical (KVPHQ) Says Bankruptcy Court Approves Hologic (HOLX) Settlement
Tweet Send to a Friend
K-V Pharmaceutical Company (OTC: KVPHQ) (NYSE: KV-A) today announced that the U. S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, approved the Company's settlement agreement with Hologic, Inc. (Nasdaq: HOLX), and authorized the Company to enter into an $85 million debtor-in-possession financing to, among other things, fund the settlement.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Procter & Gamble (PG) Sues CAO Group Over Crest Whitestrips Patents
- OCZ Technology (OCZ) Partners with NETGEAR (NTGR)
- Peregrine Pharma (PPHM), FDA Reach Agreement Over Bavituximab Phase III Design
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Bankruptcy
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
